Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer
Under a Creative Commons license
open access
Keywords
Triple negative breast cancer
Vitamin C
BET inhibitor
Combination therapy
Histone acetylation
HDAC1
Cited by (0)
© 2019 The Authors. Published by Elsevier B.V.